Literature DB >> 30214607

Glucosamine decreases the stemness of human ALDH+ breast cancer stem cells by inactivating STAT3.

Rendy Hosea1, Novi Silvia Hardiany1, Osamu Ohneda2, Septelia Inawati Wanandi1.   

Abstract

Cancer stem cells (CSCs) are a subpopulation of cancer cells responsible for tumor maintenance and relapse due to their ability to resist various anticancer effects. Owing to the resistance of CSCs to the effects of targeted therapy, an alternative strategy that targets post-translational glycosylation may be an improved approach to treat cancer as it disrupts multiple coordinated signaling that maintains the stemness of CSCs. Glucosamine acts as an anticancer agent possibly by inhibiting N-linked glycosylation. The aim of the present study was to investigate the effect of glucosamine on the stemness of breast CSCs, which is regulated by signal transducer and activator of transcription 3 (STAT3) signaling. Human aldehyde dehydrogenase-positive (ALDH+) breast CSCs and MCF7 cells were treated with various concentrations (0.25, 1 or 4 mM) of glucosamine for 24 h. Subsequently, cell viability was determined by performing a trypan blue exclusion assay, pluripotency gene [ALDH 1 family member A1 (ALDH1A1), octamer-binding transcription factor 4 (OCT-4), and Krüppel-like factor 4 (KLF4)] expression was determined using the reverse transcription-quantitative polymerase chain reaction, and STAT3 and phosphorylated STAT3 (pSTAT3) levels were determined by performing western blot analysis. Furthermore, the number of mammosphere-forming units (MFUs) in ALDH+ breast CSCs and MCF7 cells was determined. It was determined that glucosamine treatment decreased the viability of ALDH+ breast CSCs. Glucosamine treatment also decreased the stemness of ALDH+ breast CSCs and MCF7 cells, as indicated by decreased ALDH1A1, OCT-4 and KLF4 expression level, and a decreased number of MFUs. This effect of glucosamine may be associated with a decreased pSTAT3/STAT3 ratio, indicating that glucosamine inhibited STAT3 activation; therefore, the results of the present study indicated that glucosamine treatment may be an improved approach to target the stemness of CSCs.

Entities:  

Keywords:  aldehyde dehydrogenase 1 family member A1; breast cancer stem cells; glucosamine; mammosphere; signal transducer and activator of transcription 3; stemness genes

Year:  2018        PMID: 30214607      PMCID: PMC6126220          DOI: 10.3892/ol.2018.9222

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.

Authors:  Jin Ying; Masahiko Tsujii; Jumpei Kondo; Yoshito Hayashi; Motohiko Kato; Tomofumi Akasaka; Takuta Inoue; Eri Shiraishi; Tahahiro Inoue; Satoshi Hiyama; Yoshiki Tsujii; Akira Maekawa; Shoichiro Kawai; Tetsuji Fujinaga; Maekawa Araki; Shinichiro Shinzaki; Kenji Watabe; Tsutomu Nishida; Hideki Iijima; Tetsuo Takehara
Journal:  Int J Oncol       Date:  2015-01-26       Impact factor: 5.650

Review 4.  Evolution of the cancer stem cell model.

Authors:  Antonija Kreso; John E Dick
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

5.  Sox2 expression in breast tumours and activation in breast cancer stem cells.

Authors:  O Leis; A Eguiara; E Lopez-Arribillaga; M J Alberdi; S Hernandez-Garcia; K Elorriaga; A Pandiella; R Rezola; A G Martin
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

6.  Suppression of cancer relapse and metastasis by inhibiting cancer stemness.

Authors:  Youzhi Li; Harry A Rogoff; Sarah Keates; Yuan Gao; Sylaja Murikipudi; Keith Mikule; David Leggett; Wei Li; Arthur B Pardee; Chiang J Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 7.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.

Authors:  Tsukasa Shibue; Robert A Weinberg
Journal:  Nat Rev Clin Oncol       Date:  2017-04-11       Impact factor: 66.675

8.  Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

Authors:  Seog-Young Kim; Jin Wook Kang; Xinxin Song; Bo Kyoung Kim; Young Dong Yoo; Yong Tae Kwon; Yong J Lee
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

9.  The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.

Authors:  Ki-Hoon Song; Ju-Hee Kang; Jong-Kyu Woo; Jeong-Seok Nam; Hye-Young Min; Ho-Young Lee; Soo-Youl Kim; Seung-Hyun Oh
Journal:  BMC Cancer       Date:  2014-01-20       Impact factor: 4.430

10.  The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer.

Authors:  Yifeng He; Qiujing Zhu; Mo Chen; Qihong Huang; Wenjing Wang; Qing Li; Yuting Huang; Wen Di
Journal:  Oncotarget       Date:  2016-10-25
View more
  6 in total

1.  Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.

Authors:  Ting Sun; Wei Yang; Sneh M Toprani; Wei Guo; Lile He; Albert B DeLeo; Soldano Ferrone; Gong Zhang; Enwen Wang; Zunwen Lin; Pan Hu; Xinhui Wang
Journal:  Cell Commun Signal       Date:  2020-03-05       Impact factor: 5.712

2.  Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.

Authors:  Meng Pan; Miao Li; Chengzhong You; Fengshu Zhao; Mei Guo; Hui Xu; Luoyang Li; Ling Wang; Jun Dou
Journal:  J Cell Physiol       Date:  2019-07-25       Impact factor: 6.384

3.  Profiling of Gene Expression Associated with Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells.

Authors:  Septelia Inawati Wanandi; Resda Akhra Syahrani; Sekar Arumsari; Gita Wideani; Novi Silvia Hardiany
Journal:  Malays J Med Sci       Date:  2019-11-04

Review 4.  The Breast Cancer Stem Cells Traits and Drug Resistance.

Authors:  Qinghui Zheng; Mengdi Zhang; Fangfang Zhou; Long Zhang; Xuli Meng
Journal:  Front Pharmacol       Date:  2021-01-28       Impact factor: 5.810

5.  Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells.

Authors:  Eric Chang-Yi Lin; Shuoh-Wen Chen; Luen-Kui Chen; Ting-An Lin; Yu-Xuan Wu; Chi-Chang Juan; Yuan-I Chang
Journal:  Front Nutr       Date:  2021-11-10

Review 6.  Role of STAT3 signaling pathway in breast cancer.

Authors:  Jia-Hui Ma; Li Qin; Xia Li
Journal:  Cell Commun Signal       Date:  2020-02-28       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.